Ernexa Therapeutics Inc. Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal
Ernexa Therapeutics Inc. (ERNA) reported Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-20.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal · last filed 2023-03-20
- Ernexa Therapeutics Inc. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2022 was $0.00.
- Ernexa Therapeutics Inc. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2021 was -$9.65M.
| Period end | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 12 month |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-20 |
| 2021-12-31 | -$9.65M 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |